Clinical Research Directory

Inclusion Criteria: * Adult patients * With relapsing-remitting MS according to 2017 revised Mc Donald criteria * Attending medical consultation at Nantes University Hospital Neurology Department * For whom background drug therapy is needed (oral or injectable) * Who gave consent to participate in trial Exclusion Criteria: * Primary-progressive or secondary-progressive MS patients * Patients under protection of vulnerable adults measure or convicted * Patients not fluent in French * Patients with severe cognitive impairment, who may find difficult filling out questionnaires properly * Patients with a risk of follow-up interruption (move, nomadism…)